<DOC>
	<DOCNO>NCT01732848</DOCNO>
	<brief_summary>The purpose study determine rate kidney heart impairment , , subject receive BMS-986094 ( INX-08189 ) Phase 1 clinical trial</brief_summary>
	<brief_title>A Follow-up Evaluation Safety Subjects Who Participated Phase 1 Study With BMS-986094 ( INX-08189 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<criteria>Healthy hepatitis C virus ( HCV ) infect subject participate prior Phase 1 trial BMS986094/INX08189 : 1 . Received least 1 dose INX08189 2 . Received placebo study HCVinfected subject ( INH189002 INH189006 ) Age 18 older</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Volunteers</keyword>
</DOC>